AzTrials
AzTrials

Blood SugarNCT06654362

The Effect of Multimodal Nutrition Intervention on Glucose and Lipid Parameters of Arfa Iron and Steel Company Workers

A study testing nutritional interventions include education and modifying company's restaurant menu in people with Blood Sugar and Lipid Profile, run by Peyman Sarsangi at 1 site in Iran.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to investigate the impact of nutritional interventions on glycemic and lipid profile factors among workers. The main questions it aims to answer are: Does nutritional interventions (include: nutritional education and Change in the Factory Restaurant's Menu improve glycemic and lipid… Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Blood Sugar, Lipid Profile, Weight Change
What is being tested?
nutritional interventions include education and modifying company's restaurant menu
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,097 participants
Where
1 siteIran
Study dates
23 Sep 2023to 20 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • be Arfa's company worker

Who cannot join

  • individuals who were diagnosed with any type of cancer

Trial locations and contacts

1 site in 1 country.

Iran1 site
  • Shahid Sadoughi University of Medical Sciences

    Yazd

Other trials in Iran

About this study

The goal of this clinical trial is to investigate the impact of nutritional interventions on glycemic and lipid profile factors among workers.

The main questions it aims to answer are:

Does nutritional interventions (include: nutritional education and Change in the Factory Restaurant's Menu improve glycemic and lipid profile factors among workers? Researchers will compare glycemic and lipid profile factors among workers before and after nutritional intervention .

Being tested
nutritional interventions include education and modifying company's restaurant menu
Keywords
public health, workers, nutrition
Medical subject headings
Body Weight Changes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • nutritional interventions include education and modifying company's restaurant menuBehavioural

    • Reducing fried foods and replacing them with healthier alternatives.
    • Decreasing the consumption of sweetened beverages such as soda and replacing them with yogurt.
    • Reducing the intake of refined grains and substituting with whole grains.
    • Increasing fruit intake.
    • Increasing the intake of vegetables as much as possible.
    • Organizing face-to-face educational sessions with the chef to train them and improve cooking methods, to reduce fat and oil intake.
Study groups in NCT06654362
Study groupRoleWhat they receive
Arfa's company workersExperimentalall interventions administer to this arm
Receives: Behavioral: nutritional interventions include education and modifying company's restaurant menu

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total Cholesterol, mg/dL

    Measured: From enrollment to the end of intervention at 6 months

  2. Total triglycerides, mg/dL

    Measured: From enrollment to the end of intervention at 6 months

  3. Low-density lipoprotein, mg/dL

    Measured: From enrollment to the end of intervention at 6 months

  4. High-density lipoprotein, mg/dl

    Measured: From enrollment to the end of intervention at 6 months

  5. Fast blood sugar, mg/dL

    Measured: From enrollment to the end of intervention at 6 months

  6. serum glutamic oxaloacetic transaminase, IU/L

    Measured: From enrollment to the end of intervention at 6 months

  7. serum glutamic pyruvic transaminase, IU/L

    Measured: From enrollment to the end of intervention at 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Oct 2024
  2. Study start23 Sep 2023
  3. Primary completion19 Apr 2024
  4. Study completion20 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
1,097 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06654362
Sponsor's protocol ID
IRSSU.SPHREC.1402.042
Status last verified
Oct 2024
First submitted
17 Oct 2024
Last updated
23 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sarsangi P, NikAsa S, Ganji J, Fallahzadeh H, Nadjarzadeh A. The effect of multimodal nutrition intervention on glucose and lipid parameters of Arfa Iron and Steel Company workers. BMC Nutr. 2025 Jul 4;11(1):124. doi: 10.1186/s40795-025-01063-9.

    PubMed 40615890

Questions about this trial

What is this clinical trial studying?

A study testing nutritional interventions include education and modifying company's restaurant menu in people with Blood Sugar and Lipid Profile, run by Peyman Sarsangi at 1 site in Iran.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iran. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total Cholesterol, mg/dL (time frame: From enrollment to the end of intervention at 6 months). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06654362, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in